Lytix Biopharma AS (OSL:LYTIX)
9.40
+0.02 (0.21%)
Mar 4, 2026, 4:25 PM CET
90.67% (1Y)
| Market Cap | 721.32M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -59.98M |
| Shares Out | 76.90M |
| EPS (ttm) | -0.88 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 22,235 |
| Average Volume | 58,235 |
| Open | 9.64 |
| Previous Close | 9.38 |
| Day's Range | 9.30 - 9.64 |
| 52-Week Range | 4.55 - 11.90 |
| Beta | -0.46 |
| RSI | 52.52 |
| Earnings Date | Feb 12, 2026 |